| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 75.1MM | +2% |
| Gross Profit | 30.5MM | - |
| Cost Of Revenue | 44.6MM | +7% |
| Operating Income | -32.8MM | +33% |
| Operating Expenses | 63.3MM | +12% |
| Net Income | -30.3MM | +38% |
| R&D | 20.3MM | +15% |
| G&A | 15.4MM | +13% |
| Marketing | 17.3MM | +14% |
| Amortization | 7.2MM | +1% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
As the Q4 earnings season wraps, let's dig into this quarter's best and worst performers in the data analytics industry, including Palantir (NYSE:PLTR) and its peers.
Health Catalyst (HCAT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter's best and worst performers in the data analytics industry, including Domo (NASDAQ:DOMO) and its peers.
The mean of analysts' price targets for Health Catalyst (HCAT) points to a 53.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
A few Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Talkspace (TALK) and Health Catalyst (HCAT) are expected to gain from the new normal trends.
Investors who take an interest in Health Catalyst, Inc. ( NASDAQ:HCAT ) should definitely note that the CEO & Director...
SALT LAKE CITY, March 04, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of leadership will participate in the following upcoming investor conferences: The Raymond James 45th Annual Institutional Investors Conference, being held in Orlando, including a fireside chat with Jason Alger, Chief Financial Officer, and Adam Brown, Senior Vice Pres
Today, Health Catalyst announced the winner of the 2024 Flywheel Award. The award recognizes healthcare organizations that have showcased outstanding results in measurable, impactful improvements. The announcement took place at the annual Healthcare Analytics Summit (HAS), the premier event showcasing data and analytics' critical role in tackling some of healthcare's most significant challenges.
Today, approximately 1,000 healthcare leaders from around the world have gathered in Salt Lake City to kick off the 2024 Healthcare Analytics Summit (HAS) organized by Health Catalyst. In its tenth year, HAS is recognized as the premier event showcasing data and analytics' critical role in tackling some of healthcare's most significant challenges.
The heavy selling pressure might have exhausted for Health Catalyst (HCAT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.